Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Transcranial Magnetic Stimulation (TMS) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Trabectedin (Yondelis, Evdi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Total Artificial Heart (TAH) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tisotumab Vedotin-tftv (Tivdak) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Treatment of Tinnitus | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Thyrotropin Alfa (Thyrogen) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Transpupillary Thermotherapy (TTT) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Thermography | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tezepelumab-ekko (Tezspire) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tislelizumab-jsgr (Tevimbra) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Testosterone Product: (Testosterone Pellets [Testopel]) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Teplizumab-mzwv (Tzield) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Teprotumumab-trbw (Tepezza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Temsirolimus (Torisel) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Temozolomide (Temodar) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Teclistamab-cqyv (Tecvayli) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Talquetamab-tgvs(Talvey) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Treatments for Athletic Groin Pain | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Stem Cell Therapy for Peripheral Artery Disease | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ustekinumab Products: Ustekinumab (Stelara); Ustekinumab-auub (Wezlana); Ustekinumab-srlf (Imuldosa); Ustekinumab-aauz (Otulfi); Ustenkinumab-ttwe (Pyzchiva), Ustekinumab-aekn (Selarsdi); Ustenkinumab-stba (Steqeyma); Ustenkinumba-kfce (Yesintek); ustekinumab; ustekinumab-aauz, ustekinumab-stba, ustekinumab-aekn ; ustenkinumab-ttwe; Ustekinumab-hmny (Starjemza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Spesolimab-sbzo (Spevigo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Sotatercept-csrk (Winrevair) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Siltuximab (Sylvant) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Signal Averaged Electrocardiography (SAECG) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Zoster Vaccine Recombinant, Adjuvanted | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Saturation Biopsy for Diagnosis and Staging of Prostate Cancer | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Sacituzumab Govitecan-hziy (Trodelvy) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Rozanolixizumab‐noli (Rystiggo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Romidepsin [Istodax; Romidepsin (liquid)] | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Valoctocogene Roxaparvovec‐rvox (Roctavian) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Oncology Indications) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Non-Oncology Indications) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Rituximab and Hyaluronidase Human Injection (Rituxan Hycela) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Risankizumab-rzaa (Skyrizi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Rhinoplasty | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Retinal Telescreening for Diabetic Retinopathy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Retifanlimab-dlwr (Zynyz) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Remestemcel-L-rknd (Ryoncil) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ravulizumab-cwvz (Ultomiris) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ranibizumab (Susvimo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ranibizumab (Lucentis, Byooviz; Cimerli) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Radiotherapy for Prostate Cancer | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Radiofrequency Tissue Volume Reduction (RFTVR) for the Treatment of Upper Airway Obstruction | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Radioembolization for Primary Tumors and Metastatic Tumors to the Liver | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tofersen (Qalsody) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Treprostinil injection (Remodulin); Treprostinil | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Sipuleucel-T (Provenge) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Proton Beam Therapy | Metadata changed |